Maven Pet has raised $4.42 million in funding to advance its AI-Vet™ platform aimed at early detection of health issues in pets and expand its presence in the U.S. market.
Target Information
Maven Pet, a startup based in Oporto, Portugal, has recently secured $4.42 million in funding to bolster the development of its pioneering product, AI-Vet™. This innovative platform utilizes artificial intelligence to facilitate early detection of health issues in pets, aiming to revolutionize pet healthcare. Founded in 2021 by four entrepreneurs—Guilherme Coelho, David Barroso, Paulo Fonseca, and Virgílio Bento (co-founder and CEO of Sword Health)—this is the company’s third round of investment, reflecting its growth and the confidence investors have in its vision.
The AI-Vet™ system represents the first AI-based pet health monitoring platform available globally. It assists veterinarians in proactively addressing health concerns by monitoring pets’ real-time data, including physical activity and critical health metrics, through technology embedded in a collar. This distinct approach allows for timely interventions, thereby enhancing the health and longevity of thousands of pets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Portugal
The pet healthcare market in Portugal is experiencing significant expansion, driven by the increasing focus on the well-being of pets among their owners. As more individuals view pets as
Similar Deals
Grosvenor House of Investments, Portugal Ventures → PeekMed
2021
Vesalius Biocapital Partners, Armilar Venture Partners → Tonic App
2019
Codexial, Finovam Gestion, Groupe ILP, Angels Santé, Alsace Business Angels → StemInov
2026
Broadview Ventures and Advent Life Sciences → Relief Cardiovascular
2025
Touro Capital Partners
invested in
Maven Pet
in 2024
in a Series A deal
Disclosed details
Transaction Size: $4M